September 10, 2025Sexual Medicine ReviewsOpen Access

Evolving medical management of erectile dysfunction: recommendations from the Fifth International Consultation on Sexual Medicine (ICSM 2024)

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Review highlights efficacy of pharmacotherapy for erectile dysfunction and personalized treatment, suggesting evidence-based options.

PDE5 inhibitors are recommended as first-line treatment for erectile dysfunction, ensuring patient preference guides therapy decisions.
The review consolidates eight key recommendations along with corresponding evidence and grades, focusing on personalizing management.
Intracavernosal injections, vacuum erection devices, and penile prostheses are viable second-line options for erectile dysfunction treatment.
Psychosocial outcomes are essential to consider, aiming to meet the needs of both the patient and their partner in management plans.

Stern et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark